Trials / Completed
CompletedNCT00516737
Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Factorial Design Clinical Trial to Study the Efficacy and Safety of MK0462 / Rizatriptan 10 mg for the Early Treatment of Acute Migraine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the effectiveness of rizatriptan benzoate in the early treatment of an acute migraine attack.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Comparator: rizatriptan benzoate | Rizatriptan 10 mg Orally Disintegrating Tablet (ODT); one dose, treatment of a single migraine attack |
| DRUG | Comparator: Placebo | Matching placebo; one dose, treatment of a single migraine attack |
Timeline
- Start date
- 2007-10-03
- Primary completion
- 2008-04-08
- Completion
- 2008-04-08
- First posted
- 2007-08-15
- Last updated
- 2024-04-22
- Results posted
- 2009-04-14
Source: ClinicalTrials.gov record NCT00516737. Inclusion in this directory is not an endorsement.